Yujia P. Cai
Key Laboratory Of Systems Biomedicine
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Customised virus-like particles: Opening a new chapter for clinical precision gene therapy.
Journal: Clinical and translational medicine
Published: June 14, 2025
BRD9 inhibition overcomes oncolytic virus therapy resistance in glioblastoma.
Journal: Cell reports. Medicine
Published: March 27, 2025
Hexokinase-2 as a Therapeutic Target: Alleviating Herpes Simplex Keratitis Through Metabolic Reprogramming.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 26, 2025
Correction: Nuclear receptor modulators inhibit osteosarcoma cell proliferation and tumour growth by regulating the mTOR signaling pathway.
Journal: Cell death & disease
Published: February 10, 2025
Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening.
Journal: Journal of hematology & oncology
Published: January 30, 2024
Customizable virus-like particles deliver CRISPR-Cas9 ribonucleoprotein for effective ocular neovascular and Huntington's disease gene therapy.
Journal: Nature nanotechnology
Published: September 28, 2023
Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial.
Journal: Cell stem cell
Published: July 28, 2023
In vivo CRISPR gene editing in patients with herpetic stromal keratitis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 04, 2023
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers.
Journal: Nature biomedical engineering
Published: October 21, 2022
TMEFF1 is a neuron-specific restriction factor for herpes simplex virus.
Journal: Nature
Published: August 09, 2022
Last Updated: 09/26/2026